AFRM vs PMCB · P/E 590, rev $3.22B vs $8.6M cap
Affirm Holdings Inc (AFRM) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the AFRM and PMCB stock pages for the full models.
Not investment advice.